Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female aged 21- 65 years
- • Healthy, good physical condition
- • Voluntary, written, informed consent to participate in the study.
- Exclusion Criteria:
- • Serious acute or chronic diseases e.g. liver, kidney, or gastrointestinal diseases
- • Contraindication or allergies to milk thistle
- • Pregnancy or breastfeeding
- • Concurrent use of supplements and/or medications
- • Participation in another investigational study
About Isura
Isura is a pioneering clinical trial sponsor dedicated to advancing healthcare through rigorous research and innovative solutions. Specializing in the oversight and management of clinical studies, Isura is committed to ensuring the highest standards of quality, safety, and compliance throughout the trial process. With a focus on fostering collaboration among stakeholders, including researchers, healthcare providers, and regulatory bodies, Isura aims to expedite the development of effective therapies while enhancing patient outcomes. Their expertise in diverse therapeutic areas positions them as a trusted partner in navigating the complexities of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burnaby, British Columbia, Canada
Patients applied
Trial Officials
Julia Solnier, PhD
Principal Investigator
Isura
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported